PMID: 6407563Jun 4, 1983Paper

Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years

British Medical Journal
A D HibberdJ E Wells

Abstract

The long term prognosis of women with breast cancer was studied by analysing retrospectively the 30 year survival of 2019 women with histologically proved breast cancer recorded at the National Cancer Registry in New Zealand between 1950 and 1954. Excess mortality rates for successive five year survival cohorts were calculated from the survival data. From the total cohort the excess mortality rate fell rapidly during the first 10 years and then became low after 20 years. There were no significant differences in excess mortality for the age cohorts. Most of the excess mortality for 20 years was due to deaths from breast cancer. In this study the prognosis for women with breast cancer approached normal after 20 years and the improvement in prognosis resulted from decreasing death rates from breast cancer.

References

Jul 19, 1975·Lancet·D Brinkley, J L Haybrittle
Jul 1, 1979·British Journal of Cancer·J L Haybittle
Oct 2, 1976·British Medical Journal·W Duncan, G R Kerr
Nov 1, 1969·Cancer·B FisherI D Bross
Mar 15, 1982·Cancer·R D NoyesE D Montague
Nov 14, 1981·British Medical Journal·R CrotonK Griffiths

❮ Previous
Next ❯

Citations

Aug 13, 1998·Journal of Surgical Oncology·A L Feldman, J P Welch
Feb 17, 2001·Breast Cancer : the Journal of the Japanese Breast Cancer Society·M Noguchi M, T Taniya
May 19, 1984·Lancet·D Brinkley, J L Haybittle
Jul 13, 1985·Lancet
Jan 3, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Richard TaylorJohn Boyages
Dec 5, 2002·Breast Cancer Research and Treatment·Masakuni Noguchi
Aug 28, 1986·The New England Journal of Medicine·H O AdamiB Stone
Oct 29, 1992·The New England Journal of Medicine·M J McKay, A O Langlands
Aug 6, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M K Singhal, V Raina
Sep 1, 1995·The Australian and New Zealand Journal of Surgery·A O Langlands
Nov 1, 1990·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·S Toikkanen, H Joensuu
Jul 9, 1994·BMJ : British Medical Journal·H W NabJ W Coebergh
Jan 23, 2004·World Journal of Surgical Oncology·Aleyamma MathewBalakrishnan Rajan
Aug 20, 2003·Asian Journal of Surgery·Teng Aik Ong, Cheng Har Yip
Sep 3, 1998·Chest·E PikoulisP J Asimacopoulos
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M SantF Berrino
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S P ToikkanenH Joensuu
Jul 11, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·E E ElderD J Gillett
Feb 1, 1995·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H W NabW C Hop
Jun 5, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C MazouniP M Martin
Dec 24, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hermann Brenner, Timo Hakulinen
Aug 15, 1990·Cancer·S Karjalainen, E Pukkala
Aug 15, 1985·Cancer·H O AdamiB Stone
Jul 1, 1990·Statistics in Medicine·E MarubiniU Veronesi
Jan 18, 2006·The Breast Journal·Judith-Anne W ChapmanKathleen I Pritchard
Nov 25, 2004·The Oncologist·Mary Cianfrocca, Lori J Goldstein
Jun 1, 1990·Journal of Chemotherapy·U Derman
Oct 17, 2002·Oncology·Fabio LeviCarlo La Vecchia

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.